Latest filing published 18 Sept 2025 for Y-mAbs Therapeutics, Inc., €33.0M.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Johan Wedell-Wedellsborg in Y-mAbs Therapeutics, Inc., where the filings describe the role as board member. The record holds 38 filings, for trades running from 15 July 2019 to 16 September 2025.
Market trades split into 8 purchases (€2.5M) and 19 sales (€20.8M). Sales outweigh purchases by €18.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants.
Half of the purchases are above €222k and half below. Clusters matter here: 8 out of 8 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 18 September 2025, the filings show a transaction worth €33.0M in Y-mAbs Therapeutics, Inc. The most recent open-market purchase was published on 12 December 2023, 1,047 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations